Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

Saved in:
Bibliographic Details
Published inLeukemia Vol. 36; no. 5; pp. 1432 - 1435
Main Authors Komrokji, Rami S., Platzbecker, Uwe, Fenaux, Pierre, Zeidan, Amer M., Garcia-Manero, Guillermo, Mufti, Ghulam J., Santini, Valeria, Díez-Campelo, María, Finelli, Carlo, Jurcic, Joseph G., Greenberg, Peter L., Sekeres, Mikkael A., DeZern, Amy E., Savona, Michael R., Shetty, Jeevan K., Ito, Rodrigo, Zhang, George, Ha, Xianwei, Backstrom, Jay T., Verma, Amit
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.05.2022
Nature Publishing Group
Subjects
692/308/2779/777
692/699/67/1990/1673
Activin Receptors, Type II
Anemia
Anemia, Sideroblastic
Blood platelets
Cancer Research
Cancer therapies
Critical Care Medicine
Hematology
Hemoglobin
Humans
Immunoglobulin Fc Fragments
Intensive
Internal Medicine
Letter
Leukemia
Medicine
Medicine & Public Health
Mutation
Myelodysplastic syndrome
Myelodysplastic syndromes
Myelodysplastic Syndromes - drug therapy
Myelodysplastic Syndromes - genetics
Myelodysplastic-Myeloproliferative Diseases - drug therapy
Myelodysplastic-Myeloproliferative Diseases - genetics
Neoplasms
Oncology
Patients
Population
Recombinant Fusion Proteins
Sideroblasts
Thrombocytosis
Thrombocytosis - drug therapy
Tumors
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0887-6924
1476-5551
DOI:10.1038/s41375-022-01521-4